BioCatalystWatch
CELCWorkspace / CELC / OverviewCompany library
Price
Market cap
Next catalystLate 2026 at SABCS; December 8–11 meeting windowREVTORPYK (gedatolisib) · Phase 3 dataSEC filing ↗
Cash

Chart & Events

Candle interval

Core Clinical

REVTORPYK (gedatolisib)Gedatolisib — VIKTORIA-2 Study 1

Class I PI3K (α/β/γ/δ) × mTORC1 × mTORC2

PreINDP1P2P3FilingApproved
Upcoming / outlook

REVTORPYK (gedatolisib)

Class I PI3K (α/β/γ/δ) × mTORC1 × mTORC2

PreINDP1P2P3FilingApproved

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

REVTORPYK (gedatolisib)Gedatolisib — VIKTORIA-2 Study 1

Class I PI3K (α/β/γ/δ) × mTORC1 × mTORC2

PreINDP1P2P3FilingApproved
Upcoming / outlook

REVTORPYK (gedatolisib)

Class I PI3K (α/β/γ/δ) × mTORC1 × mTORC2

PreINDP1P2P3FilingApproved

Other pipelines

REVTORPYK (gedatolisib)

Class I PI3K (α/β/γ/δ) × mTORC1 × mTORC2

PreINDP1P2P3FilingApproved
Upcoming / outlook

REVTORPYK (gedatolisib)

Class I PI3K (α/β/γ/δ) × mTORC1 × mTORC2

REVTORPYK (gedatolisib)

Class I PI3K (α/β/γ/δ) × mTORC1 × mTORC2

PreINDP1P2P3FilingApproved
REVTORPYK (gedatolisib)

Class I PI3K (α/β/γ/δ) × mTORC1 × mTORC2

Approved / commercial

REVTORPYK (gedatolisib)

Class I PI3K (α/β/γ/δ) × mTORC1 × mTORC2

Approved

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Financial position

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

CELC SEC archive